» Authors » A Neubauer

A Neubauer

Explore the profile of A Neubauer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 235
Citations 5011
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasenfuss G, Hallek M, Neubauer A
Inn Med (Heidelb) . 2023 Aug; 64(9):820-822. PMID: 37612568
No abstract available.
2.
Maurer E, Eilsberger F, Wachter S, Riera Knorrenschild J, Pehl A, Holzer K, et al.
Eur Arch Otorhinolaryngol . 2023 Jan; 280(3):1509-1518. PMID: 36637521
Introduction: Few available data indicate that a mutation-based "neoadjuvant" therapy in advanced anaplastic thyroid carcinoma (ATC) might convert an initially unresectable primary tumor to resectable and optimize local tumor control....
3.
Hackstein H, Kalina A, Dorn B, Keil I, Baal N, Michel G, et al.
Clin Exp Immunol . 2020 Oct; 203(2):329-339. PMID: 33073358
Extracorporeal photopheresis (ECP) represents one of the most widespread and effective cell therapies for graft-versus-host disease and other T cell-mediated disorders. However, the key factors affecting the therapeutic efficacy of...
4.
Niklowitz P, Hirschberger M, Lucas M, cermak P, Schneidewind A, Faulhaber E, et al.
Phys Rev Lett . 2020 Jan; 123(24):247203. PMID: 31922868
In the metallic magnet Nb_{1-y}Fe_{2+y}, the low temperature threshold of ferromagnetism can be investigated by varying the Fe excess y within a narrow homogeneity range. We use elastic neutron scattering...
5.
Mossner J, Neubauer A
Internist (Berl) . 2019 Sep; 60(10):1009-1013. PMID: 31560084
No abstract available.
6.
Hoffmann J, Michel C, Schindler T, Wollmer E, Neubauer A
Internist (Berl) . 2018 Jul; 59(10):1106-1113. PMID: 30046890
The examination of peripheral blood smears is not only essential for the differential diagnostics of hematological diseases but can also provide important indications for general internal diseases, infections, hereditary diseases...
7.
Schutz C, Inselmann S, Saussele S, Dietz C, Muller M, Eigendorff E, et al.
Leukemia . 2018 Jan; 32(4):1054. PMID: 29381150
This corrects the article DOI: 10.1038/leu.2017.9.
8.
Metzelder S, Schroeder T, Lubbert M, Ditschkowski M, Gotze K, Scholl S, et al.
Eur J Cancer . 2017 Oct; 86:233-239. PMID: 29055209
Background: Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia (AML) relapsing after allogeneic stem cell transplantation (allo-SCT) has a dismal prognosis with limited therapeutic options. FLT3-ITD kinase...
9.
Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb H, et al.
Leukemia . 2017 Aug; 31(11):2398-2406. PMID: 28804124
Chronic myeloid leukemia (CML)-study IV was designed to explore whether treatment with imatinib (IM) at 400 mg/day (n=400) could be optimized by doubling the dose (n=420), adding interferon (IFN) (n=430)...
10.
Krause S, Neubauer A
Internist (Berl) . 2017 May; 58(6):545-549. PMID: 28497377
Many new diagnostic and therapeutic options have been introduced in the field of hematology and medical oncology during recent years. Rational treatment recommendations are thus of even greater importance. Five...